Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsJulie Dewey - Chief Investor Relations ...

Learn the 5 strategies that reduce diabetes-related amputation risk, from proper foot examinations and self-monitoring to ...

MolecuLight Corp. further strengthened its market position in June 2022 through a group purchasing agreement with Premier, ...

MED's second product, is being developed to provide safe, real-time optical readings of biomarkers for assessment of diabetic ...

The Cuban business conglomerate BioCubaFarma has entered into a biotechnological and pharmaceutical cooperation agreement ...

Microbion Phase 2 study shows favorable safety and early efficacy data, with 46.7% of patients treated achieving complete wound closure. A ...

When you think of the early warning signs of diabetes, skin problems likely aren't the first thing to come to mind. But our ...

See other news and announcements from the Amarillo area business community here, including a rooftop patio bar and upcoming ...

Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed studies describing the efficacy of the company's ...

Proven cold plasma therapy system for chronic wound treatment represents patient-first innovation. The Plasoma cold plasma system represents the kind of patient-first innovation our industry needs.” — ...

This agreement will introduce a new technology that has already demonstrated strong results in promoting wound healing to the ...

Complete A to Z disease and conditions health guide which provides information on a wide range of diseases and its symptoms, treatment, prevention and cure at thehealthsite.com ...